Abstract
Hypertension is a common cardiovascular risk factor leading to heart failure (HF), coronary artery disease, stroke, peripheral artery disease and chronic renal insufficiency. Hypertensive heart disease can manifest as many cardiac arrhythmias, most commonly being atrial fibrillation (AF). Both supraventricular and ventricular arrhythmias may occur in hypertensive patients, especially in those with left ventricular hypertrophy (LVH) or HF. Also, some of the antihypertensive drugs commonly used to reduce blood pressure, such as thiazide diuretics, may result in electrolyte abnormalities (e.g. hypokalaemia, hypomagnesemia), further contributing to arrhythmias, whereas effective control of blood pressure may prevent the development of the arrhythmias such as AF. In recognizing this close relationship between hypertension and arrhythmias, the European Heart Rhythm Association (EHRA) and the European Society of Cardiology (ESC) Council on Hypertension convened a Task Force, with representation from the Heart Rhythm Society (HRS), Asia-Pacific Heart Rhythm Society (APHRS), and Sociedad Latinoamericana de Estimulación Cardíaca y Electrofisiología (SOLEACE), with the remit to comprehensively review the available evidence to publish a joint consensus document on hypertension and cardiac arrhythmias, and to provide up-to-date consensus recommendations for use in clinical practice. The ultimate judgment regarding care of a particular patient must be made by the healthcare provider and the patient in light of all of the circumstances presented by that patient.
| Original language | English |
|---|---|
| Pages (from-to) | 891-911 |
| Number of pages | 21 |
| Journal | Europace |
| Volume | 19 |
| Issue number | 6 |
| DOIs | |
| Publication status | Published - 2017 Jun 1 |
Fingerprint
Keywords
- Arrhythmias
- Atrial fibrillation
- EHRA consensus document
- Hypertension
- Left ventricular hypertrophy
ASJC Scopus subject areas
- Cardiology and Cardiovascular Medicine
- Physiology (medical)
Cite this
Hypertension and cardiac arrhythmias : A consensus document from the European Heart Rhythm Association (EHRA) and ESC Council on Hypertension, endorsed by the Heart Rhythm Society (HRS), Asia-Pacific Heart Rhythm Society (APHRS) and Sociedad Latinoamericana de Estimulación Cardíaca y Electrofisiología (SOLEACE). / Lip, Gregory Y.H.; Coca, Antonio; Kahan, Thomas; Boriani, Giuseppe; Manolis, Antonis S.; Olsen, Michael Hecht; Oto, Ali; Potpara, Tatjana S.; Steffel, Jan; Marín, Francisco; De Oliveira Figueiredo, Márcio Jansen; De Simone, Giovanni; Tzou, Wendy S.; Chiang, Chern En; Williams, Bryan; Dan, Gheorghe Andrei; Gorenek, Bulent; Fauchier, Laurent; Savelieva, Irina; Hatala, Robert; Van Gelder, Isabelle; Brguljan-Hitij, Jana; Erdine, Serap; Lovic, Dragan; Kim, Young Hoon; Salinas-Arce, Jorge; Field, Michael.
In: Europace, Vol. 19, No. 6, 01.06.2017, p. 891-911.Research output: Contribution to journal › Article
}
TY - JOUR
T1 - Hypertension and cardiac arrhythmias
T2 - A consensus document from the European Heart Rhythm Association (EHRA) and ESC Council on Hypertension, endorsed by the Heart Rhythm Society (HRS), Asia-Pacific Heart Rhythm Society (APHRS) and Sociedad Latinoamericana de Estimulación Cardíaca y Electrofisiología (SOLEACE)
AU - Lip, Gregory Y.H.
AU - Coca, Antonio
AU - Kahan, Thomas
AU - Boriani, Giuseppe
AU - Manolis, Antonis S.
AU - Olsen, Michael Hecht
AU - Oto, Ali
AU - Potpara, Tatjana S.
AU - Steffel, Jan
AU - Marín, Francisco
AU - De Oliveira Figueiredo, Márcio Jansen
AU - De Simone, Giovanni
AU - Tzou, Wendy S.
AU - Chiang, Chern En
AU - Williams, Bryan
AU - Dan, Gheorghe Andrei
AU - Gorenek, Bulent
AU - Fauchier, Laurent
AU - Savelieva, Irina
AU - Hatala, Robert
AU - Van Gelder, Isabelle
AU - Brguljan-Hitij, Jana
AU - Erdine, Serap
AU - Lovic, Dragan
AU - Kim, Young Hoon
AU - Salinas-Arce, Jorge
AU - Field, Michael
PY - 2017/6/1
Y1 - 2017/6/1
N2 - Hypertension is a common cardiovascular risk factor leading to heart failure (HF), coronary artery disease, stroke, peripheral artery disease and chronic renal insufficiency. Hypertensive heart disease can manifest as many cardiac arrhythmias, most commonly being atrial fibrillation (AF). Both supraventricular and ventricular arrhythmias may occur in hypertensive patients, especially in those with left ventricular hypertrophy (LVH) or HF. Also, some of the antihypertensive drugs commonly used to reduce blood pressure, such as thiazide diuretics, may result in electrolyte abnormalities (e.g. hypokalaemia, hypomagnesemia), further contributing to arrhythmias, whereas effective control of blood pressure may prevent the development of the arrhythmias such as AF. In recognizing this close relationship between hypertension and arrhythmias, the European Heart Rhythm Association (EHRA) and the European Society of Cardiology (ESC) Council on Hypertension convened a Task Force, with representation from the Heart Rhythm Society (HRS), Asia-Pacific Heart Rhythm Society (APHRS), and Sociedad Latinoamericana de Estimulación Cardíaca y Electrofisiología (SOLEACE), with the remit to comprehensively review the available evidence to publish a joint consensus document on hypertension and cardiac arrhythmias, and to provide up-to-date consensus recommendations for use in clinical practice. The ultimate judgment regarding care of a particular patient must be made by the healthcare provider and the patient in light of all of the circumstances presented by that patient.
AB - Hypertension is a common cardiovascular risk factor leading to heart failure (HF), coronary artery disease, stroke, peripheral artery disease and chronic renal insufficiency. Hypertensive heart disease can manifest as many cardiac arrhythmias, most commonly being atrial fibrillation (AF). Both supraventricular and ventricular arrhythmias may occur in hypertensive patients, especially in those with left ventricular hypertrophy (LVH) or HF. Also, some of the antihypertensive drugs commonly used to reduce blood pressure, such as thiazide diuretics, may result in electrolyte abnormalities (e.g. hypokalaemia, hypomagnesemia), further contributing to arrhythmias, whereas effective control of blood pressure may prevent the development of the arrhythmias such as AF. In recognizing this close relationship between hypertension and arrhythmias, the European Heart Rhythm Association (EHRA) and the European Society of Cardiology (ESC) Council on Hypertension convened a Task Force, with representation from the Heart Rhythm Society (HRS), Asia-Pacific Heart Rhythm Society (APHRS), and Sociedad Latinoamericana de Estimulación Cardíaca y Electrofisiología (SOLEACE), with the remit to comprehensively review the available evidence to publish a joint consensus document on hypertension and cardiac arrhythmias, and to provide up-to-date consensus recommendations for use in clinical practice. The ultimate judgment regarding care of a particular patient must be made by the healthcare provider and the patient in light of all of the circumstances presented by that patient.
KW - Arrhythmias
KW - Atrial fibrillation
KW - EHRA consensus document
KW - Hypertension
KW - Left ventricular hypertrophy
UR - http://www.scopus.com/inward/record.url?scp=85021828954&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85021828954&partnerID=8YFLogxK
U2 - 10.1093/europace/eux091
DO - 10.1093/europace/eux091
M3 - Article
C2 - 28881872
AN - SCOPUS:85021828954
VL - 19
SP - 891
EP - 911
JO - Europace
JF - Europace
SN - 1099-5129
IS - 6
ER -